4
Changes in Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-25-012532
CHIEF ACCOUNTING OFFICER sold 17,647 shares at $26.69 ($470,998)
- CHIEF ACCOUNTING OFFICER acquired 17,647 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2025-05-07 | Option exercise 10b5-1 | +229 | $8.83 | $2,022 | 32,775 | D |
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2025-05-07 | Option exercise 10b5-1 | +2,998 | $15.50 | $46,469 | 35,773 | D |
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2025-05-07 | Option exercise 10b5-1 | +14,420 | $11.97 | $172,607 | 50,193 | D |
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2025-05-07 | Sale 10b5-1 | −17,647 | $26.69 | $470,998 | 32,546 | D |
| Derivatives | |||||||
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2025-05-07 | Option exercise · Share Option 10b5-1 | −229 | 0 | D | ||
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2025-05-07 | Option exercise · Share Option 10b5-1 | −2,998 | 16,002 | D | ||
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2025-05-07 | Option exercise · Share Option 10b5-1 | −14,420 | 17,040 | D | ||
| Open-market sales · 17,647 sh · avg $26.69 · $470,998 | |||||||
Loading xslF345X05/form4-05092025_080544.xml…